Futuristic smart grill with digital interface and glowing heat cooking a steak while being controlled from a smartphone, representing AI-powered outdoor cooking technology.

Smart Grill Tech 2026: From AI Steaks in 90 Seconds to the Future of Neural-Grilling

Grilling has gone digital. From AI-controlled heat to app-connected smokers, smart grills are turning backyard BBQ into a high-tech experience. Here’s your FUNanc1al guide to the future of grilling—and which one to buy.

Read entire article

Split illustration showing a stressed human driver in traffic versus a calm futuristic robotaxi driving autonomously through a smart city, symbolizing the shift to AI-powered autonomous vehicles and the robotaxi investment boom.

The Robotaxi Revolution: How to Trade the $550B Autonomous Vehicle Boom

Robotaxis are no longer a demo—they’re a business. From Waymo and Baidu to Tesla and Microsoft, autonomous vehicles are scaling fast toward a $550B market. Here’s the fun, clear, investor-ready guide to the Driverless Dividend.

 

Read entire article

Illustration of a reusable rocket launching toward orbit with a space station, the Moon, and Mars in the background, symbolizing the new era of commercial space travel and the growing space economy.

Space 2.0: The “Southwest Airlines” of the Stars Is Now Boarding

Reusable rockets are flipping space from science project to industry. From $10M orbit “cruises” to AI, biotech, and new space stocks, 2026 looks like the aviation moment for space.

 

Read entire article

Cartoon DNA strand curling into a rocket blasting off from a beaker labeled ‘CRISPR Therapeutics,’ with smiling triglycerides fleeing the scene — symbolizing the company’s cholesterol-editing breakthrough

Will Gene Editing Stocks Ever Get Hot? If Not, Make Them CRISPR!

CRISPR Therapeutics (CRSP) just dropped jaw-dropping Phase 1 data: one IV treatment lowered triglycerides and LDL by up to 80%+ — safely. That’s not just biotech progress; it’s medical sci-fi turned reality. With insiders buying and gene-editing stocks heating up again, the question isn’t if CRISPR will change medicine — it’s whether it can change your portfolio.

Read entire article